IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Obalon Therapeutics Inc

CUSIP: 67424L100 | 107 institutional holders

Quarters

Q1 2020Q4 2019Q3 2019Q2 2019Q1 2019
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q1 2020

Proequities, Inc.0
0.0% of portfolio›$0
StyleTurnoverLocationFiled
Proequities, Inc.
0$00.0%GrowthVery LowBirmingham, AL2020-05-13